Skip to content

Drug interactions

Indacaterol-glycopyrronium + Vorinostat

Severity: Moderate

Indacaterol-glycopyrronium and Vorinostat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vorinostat has been associated with QT prolongation and electrolyte disturbances, and indacaterol can contribute to hypokalemia and arrhythmias. The combination may increase risk of ventricular arrhythmia.

What this interaction means in plain words

Indacaterol-glycopyrronium and Vorinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Indacaterol-glycopyrronium belongs to Respiratory; Vorinostat belongs to Oncology.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization and potential for electrolyte disturbance.

What to do

Check baseline ECG, potassium, magnesium and calcium and monitor periodically. Correct abnormalities before and during therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Vorinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Vorinostat?

MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Vorinostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Vorinostat has been associated with QT prolongation and electrolyte disturbances, and indacaterol can contribute to hypokalemia and arrhythmias. The combination may increase risk of ventricular arrhythmia.

How serious is the interaction between Indacaterol-glycopyrronium and Vorinostat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG, potassium, magnesium and calcium and monitor periodically. Correct abnormalities before and during therapy.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in